Bifei Li
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Extracellular vesicles in disease 5
- Lipid Membrane Structure and Behavior 5
- RNA Interference and Gene Delivery 3
-
- Nanoplatforms for cancer theranostics 9
- Graphene and Nanomaterials Applications 3
- Co-authors
- Lee Jia (17 shared papers)Huifang Nie (6 shared papers)Xiaodong Xie (5 shared papers)Doudou Zhang (5 shared papers)Jian Liu (7 shared papers)Yunlong Cheng (3 shared papers)Yu Zhou (5 shared papers)Junxia Zheng (6 shared papers)
- Journals
- Chemical Engineering Journal (3 papers)Nature Communications (2 papers)Journal of Nanobiotechnology (2 papers)Journal of Colloid and Interface Science (2 papers)Pharmaceutics (1 paper)
- Partner nations
- ChinaRussiaSwitzerland
In The Last Decade
Bifei Li
30 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 251
- Biomaterials 190
- Molecular Biology 683
- Biomedical Engineering 384
- Immunology 163
Countries citing papers authored by Bifei Li
This map shows the geographic impact of Bifei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bifei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bifei Li more than expected).
Fields of papers citing papers by Bifei Li
This network shows the impact of papers produced by Bifei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bifei Li. The network helps show where Bifei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Bifei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 197 | |
| 2 | 2021 | 107 | |
| 3 | 2019 | 104 | |
| 4 | 2019 | 89 | |
| 5 | 2019 | 88 | |
| 6 | 2020 | 61 | |
| 7 | 2019 | 57 | |
| 8 | 2022 | 56 | |
| 9 | 2021 | 49 | |
| 10 | 2019 | 44 | |
| 11 | 2019 | 42 | |
| 12 | 2019 | 42 | |
| 13 | 2018 | 41 | |
| 14 | 2019 | 36 | |
| 15 | 2018 | 29 | |
| 16 | 2019 | 29 | |
| 17 | 2019 | 24 | |
| 18 | 2020 | 22 | |
| 19 | 2021 | 17 | |
| 20 | 2021 | 16 |
About Bifei Li
Bifei Li is a scholar working on Molecular Biology, Biomedical Engineering, Atomic and Molecular Physics, and Optics, Oncology and Biophysics, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), Spectroscopy and Quantum Chemical Studies (6 papers), Extracellular vesicles in disease (5 papers), Lipid Membrane Structure and Behavior (5 papers), Advanced Fluorescence Microscopy Techniques (4 papers), MicroRNA in disease regulation (4 papers), RNA Interference and Gene Delivery (3 papers) and Graphene and Nanomaterials Applications (3 papers). The work is most often cited by research in Cancer Research (251 citations), Biomaterials (190 citations), Molecular Biology (683 citations), Biomedical Engineering (384 citations) and Immunology (163 citations). Bifei Li has collaborated with scholars based in China, Russia and Switzerland. Frequent co-authors include Lee Jia, Huifang Nie, Xiaodong Xie, Doudou Zhang, Jian Liu, Yunlong Cheng, Yu Zhou, Junxia Zheng, Yumei Li and Yusheng Lu. Their work appears in journals such as Chemical Engineering Journal, Nature Communications, Journal of Nanobiotechnology, Journal of Colloid and Interface Science and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.